close this section of the library6. Quality Assurance and Drug Safety
open this document and view contentsCounterfeit drugs (WHO/EDM, 1999, 61 p.)
open this document and view contentsDrug quality control laboratories (WHO/AFRO, 1999, 41 p.)
open this document and view contentsGeneral principles for guidance in devising International Nonproprietary Names for pharmaceutical substances (WHO/EDM, 25 p.)
open this document and view contentsGuidelines for good clinical practice (GCP) for trials on pharmaceutical products (WHO Technical Report Series, No. 850, 1995, Annex 3) (WHO, 1995, 36 p.)
open this document and view contentsIndex of pharmacopoeias (WHO/EDM, 2001, 10 p.)
open this document and view contentsMédicaments contrefaits : Guide pour l'élaboration de mesures visant à éliminer les médicaments contrefaits (OMS/EDM, 2000, 64 p.)
open this document and view contentsProcedure for the selection of Recommended International Nonproprietary Names for pharmaceutical substances (WHO/EDM, 3 p.)
open this document and view contentsReference substances and infrared reference spectra for pharmacopoeial analysis (WHO/EDM, 1999, 117 p.)
open this document and view contentsStarting materials for pharmaceutical products: Control and safe trade (WHO/DMP, 1998, 10 p.)